Profile
SYBX VRTX REGN SGEN ALNY ARGX
Company Name Synlogic, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $14.74M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.00K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Ms. Mary Beth Dooley Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
SYBX VRTX REGN SGEN ALNY ARGX
Quant Rating Score 4 2 4 3 1 2
Quant Rating Buy Sell Buy Neutral Strong Sell Sell
Trading
SYBX VRTX REGN SGEN ALNY ARGX
Last Close $1.18 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $1.72 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $0.97 $396.64 $482.92 $228.74 $224.58 $435.29
Price vs. 52 Week High -31.4 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 21.65 % 15.88 % 13.34 % 0 % 47.79 % 24.85 %
Total Return
SYBX VRTX REGN SGEN ALNY ARGX
1 Month Return -4.07 % 3.09 % 12.88 % 0 % 8.71 % -5.24 %
3 Month Return 9.26 % -3.16 % -4.54 % 0 % 40.79 % -2.1 %
6 Month Return -18.5 % 12.9 % -23.78 % 0 % 41.67 % -12.52 %
9 Month Return -21.33 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return -15.71 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return -19.18 % -2.27 % -46.55 % 0 % 33.47 % 24.85 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYBX VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -46.78 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
SYBX VRTX REGN SGEN ALNY ARGX
Asset Growth -73.76 % -0.87 % 36.55 %
Gross Profit Growth -99.76 % 10.25 % 77.08 %
Revenue Growth -99.76 % 11.66 % 78.6 %
Revenue 3 Year -99.86 % 45.6 % 275.84 %
Revenue 5 Year -99.94 % 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth 59.22 % -93.69 % 128.87 %
Net Income Growth 59.22 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 87.84 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 92.06 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 86.3 % 33.84 % 938.02 %
Operating Income Growth 25.76 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 38.66 % -113.93 % 80.31 %
Operating 3 Year CFG 81.66 % -118.65 % 88.36 %
Operating 5 Year CFG 93.06 % -131.3 % -135.21 %
Operating 10 Year CFG 78.95 % 12.43 % -64 %
EPS Growth 78.21 % -114.8 % 369.77 %
EPS Diluted Growth 78.21 % -114.97 % 347.67 %
Book Value Per Share -84.06 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -97.38 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -98.65 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 102.47 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -100 % 116.42 % 95.27 %
Free Cash Flow Growth 38.89 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
SYBX VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM 8.34 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM 10.91 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -22.94 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 99.67 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM -50.05 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.45 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.42 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 140.6 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 97.86 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.84 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.87 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.87 -119.36 14.77 -93.1 -914.84 -515.98
Income Statement (TTM)
SYBX VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.02B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1.92 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
SYBX VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.01B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.02B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
SYBX VRTX REGN SGEN ALNY ARGX
Net Income $-0.02B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.81
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.8
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.76
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.14
ABVX Abivax SA American Depositary Shares 7.9
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.23
ACIU AC Immune SA 2.07
ETFs With Exposure to SYBX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 136.82
VXF Vanguard Extended Market Index Fund 0.00004 197.5
IWC iShares Micro-Cap ETF 0.00835 133.09
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.79
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.17
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.16
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.17
DFAU Dimensional US Core Equity Market ETF 0 42.97
DFAT Dimensional U.S. Targeted Value ETF 0.000155 56.35
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
INNO Harbor Disruptive Innovation ETF 0 17.72
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00004 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000630922 106.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00004 149.83
DFQTX DFA U.S. Core Equity 2 Portfolio 0 40.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00004 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
Unlock